glp-1 size Analogues Market Size, Trends, Growth Report 2032 GLP-1 Receptor Agonist Market Size,

A dependable support channellive chat, email, or hotlinerounds out the experience by providing answers when you actually need them, not hours later, so your momentum never stalls

ISSN 0214-6282

Standard clinical dose escalation The FDA-approved Mounjaro (brand tirzepatide) follows this schedule: Weeks 1-4: 2.5 mg once weekly (starting dose, allows GI adaptation) Weeks 5-8: 5 mg once weekly (first therapeutic dose increase) Weeks 9-12: 7.5 mg once weekly (if tolerated and additional effect needed) Weeks 13-16: 10 mg once weekly (continued escalation) Weeks 17-20: 12.5 mg once weekly (approaching maximum) Week 21+: 15 mg once weekly (maximum approved dose) Each dose is maintained for at least four weeks before escalation

After patients reach a healthy and stable weight, they stay on the highest dose they are tolerating in order to maintain their current weight